Condition: Atrial Fibrillation (Paroxysmal) · Sponsor: CardioFocus
This is a prospective, single-arm First-in-Human study to demonstrate the safety and effectiveness of the CardioFocus OptiShot Pulsed Field Ablation System for catheter ablation of atrial fibrillation (AF). Patients with symptomatic paroxysmal (short-duration) AF who have not had a previous catheter ablation for AF will be considered for the study. Patients will be followed for one year after the initial ablation procedure.
This description comes directly from the study's public registry record.
Vikramaditya Mediratta, MS · 714-717-2376 · vmediratta@cardiofocus.com
Lisa Hausmann, MPH · 508-658-7253 · lhausmann@cardiofocus.com
Always discuss trial participation with your own doctor first.
| Na Homolce Hospital | Prague, Czech Republic, Czechia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06828939